Search Results

Propensity score analysis of high-dose rate brachytherapy, immune checkpoint inhibitors, and docetaxel in second-line advanced NSCLC treatment.

• Authors : Cui, Ran¹ (AUTHOR); Su, Hong¹ (AUTHOR); Jiang, Yan² (AUTHOR)

• Source: Scientific Reports. 4/12/2025, Vol. 15 Issue 1, p1-13. 13p.

Record details

State of the Art of Immune Checkpoint Inhibitors in Unresectable Pancreatic Cancer: A Comprehensive Systematic Review.

• Authors : Orlandi, Elena¹ (AUTHOR) ; Guasconi, Massimo^2,3 (AUTHOR); Romboli, Andrea^3,4 (AUTHOR)

Subjects: *CLINICAL trials; *IMMUNE checkpoint inhibitors; *ADVERSE health care events

• Source: International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 6, p2620. 21p.

Record details

Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database.

• Authors : Dong, Zi-Yue¹ (AUTHOR); He, Ming-Jie² (AUTHOR); Hu, Yuan³ (AUTHOR)

• Source: Dermatologic Therapy. 4/8/2025, Vol. 2025, p1-12. 12p.

Record details

Immune Checkpoint Inhibitors and Liver Transplantation: Case Report and Review of the Literature.

• Authors : Skocilic, Iva¹ (AUTHOR); Kosic, Alojzije¹ (AUTHOR); Badovinac, Ivona¹ (AUTHOR)

• Source: Clinical Case Reports. Apr2025, Vol. 13 Issue 4, p1-5. 5p.

Record details

幽门螺杆菌对胃癌免疫检查点抑制剂疗效影响的研究进展.

• Authors : 李麻图^1,2,3 ; 郑亚^2,3; 赵进玉^1,4

• Source: Chinese Journal of Immunology. Mar2025, Vol. 41 Issue 3, p727-732. 6p.

Record details

Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors.

• Authors : van Lent, Anouk^1,2 (AUTHOR); Puscasu, Rebeca^1,2 (AUTHOR); Kaasjager, Karin A. H.³ (AUTHOR)

Subjects: *VENOUS thrombosis; *IMMUNE checkpoint inhibitors; *PROPORTIONAL hazards models

• Source: PLoS ONE. 4/1/2025, Vol. 20 Issue 4, p1-14. 14p.

Record details

The Challenging Scenario of Cancer Treatment for People with HIV: Clinical Experience with Immune Checkpoint Inhibitors.

• Authors : Franchina, Tindara¹ (AUTHOR); Carroccio, Patrizia^1,2 (AUTHOR); Russotto, Ylenia^2,3 (AUTHOR)

• Source: Current Oncology. Mar2025, Vol. 32 Issue 3, p164. 9p.

Record details

Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database.

• Authors : Koseki, Takenao¹ (AUTHOR) ; Hamano, Hirofumi^2,3 (AUTHOR); Hatano, Masakazu^1,3 (AUTHOR)

• Source: Pharmaceuticals (14248247). Mar2025, Vol. 18 Issue 3, p333. 10p.

Record details

皮肤不良反应作为免疫检查点抑制剂治疗的 挑战:研究进展与未来方向.

• Authors : 王燕¹; 左亚刚¹

• Source: Chinese Journal of Dermatovenereology. Dec2024, Vol. 38 Issue 12, p1305-1311. 7p.

Record details

Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors.

• Authors : Fu, Xiaona^1,2 (AUTHOR); Guo, Yusheng^1,2 (AUTHOR); Zhang, Kailu^1,2 (AUTHOR)

• Source: Scientific Reports. 4/20/2025, Vol. 15 Issue 1, p1-14. 14p.

Record details